Our study shows that even short-term treatment with dipeptidyl peptidase 4 inhibitors can significantly slow the progress of cognitive impairment in mice, indicating the potential therapeutic value of this type of disorder. This evidence concerns the gene DPP4 and Cognitive impairment.